Trial Profile
Phase IIa trial investigating verubulin with and without oxaliplatin in patients with recurring glioblastoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2011
Price :
$35
*
At a glance
- Drugs Verubulin (Primary) ; Oxaliplatin
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 08 Sep 2011 Status changed from recruiting to completed.
- 03 Feb 2011 Data from a second sub-group of recurrent glioblastoma patients who are naive to Avastin are expected in the first half of 2011, according to a Myrexis media release.
- 16 Sep 2008 Preliminary tolerability results presented at ESMO